Fed Chair Jerome Powell is trying to keep a lid on inflation. Photo by Nathan Posner/ShutterstockFed Chair Jerome Powell is trying to keep a lid on inflation. Photo by Nathan Posner/Shutterstock

Bitcoin, Ethereum prices drop on hot inflation data ahead of Fed meeting

2026/03/19 02:43
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Bitcoin’s price dropped further on Wednesday as traders digested hotter-than-expected US inflation data and awaited the Federal Reserve’s rate policy decision.

Over the past day, the coin has dropped by nearly 4%, and was recently priced at $71,622, according to CoinGecko. Ethereum dropped further — nosediving by 6% — and was priced at $2,181.

The selloff comes after the biggest coin started flirting with $76,000 last week — its highest level in over a month. Analysts believed it was decoupling from risk assets as stocks took a hit.

But investors continued to derisk Wednesday as inflation data came in worse than expected and the war in Iran escalated, with US equities and crypto both taking a hit.

James Butterfill, head of research at European asset manager CoinShares, told DL News that the fall in prices could be due to fears over what the Fed will say at the Federal Open Market Committee meeting.

“I have seen the futures market rate cut expectations for June fall further, suggesting forward guidance from the Fed will be quite hawkish given rising oil prices,” he added.

Rising oil prices to hurt Bitcoin

Oil prices continued to climb Wednesday on news that Israel had hit Iran’s South Pars gas field.

Experts previously told DL News that rising energy prices lead to higher inflation, in turn postponing interest rate cuts from central banks. Crypto markets have typically performed better in a low interest rate environment.

Now, with war raging in the Middle East, oil prices could continue to rocket up. Last week, Iran’s military spokesman warned oil prices could double due to the war.

All eyes on the Fed

Now, traders will be eyeing up what Fed Chair Jerome Powell says following the meeting on Wednesday.

Samuel Leyne, co-head of crypto trading at Marex, told DL News that the dip in crypto prices was likely down to traders positioning ahead of the event.

“The Fed decision is still ahead, so part of this is also pre-event positioning and profit taking rather than a reaction to the Fed itself,” he said.

Fed officials are expected to hold rates steady in the second meeting of 2026, but any signs from Powell after the meeting that the central bank may raise interest rates later in the year could lead to a shift in the market.

Mathew Di Salvo is a news correspondent with DL News. Got a tip? Email at mdisalvo@dlnews.com.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26